gabapentin

Generic: gabapentin

Labeler: zhejiang yongtai pharmaceutical co., ltd
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler zhejiang yongtai pharmaceutical co., ltd
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

gabapentin 300 mg/1

Manufacturer
Zhejiang Yongtai Pharmaceutical Co., Ltd

Identifiers & Regulatory

Product NDC 69434-043
Product ID 69434-043_457c0aa0-f1e5-d420-e063-6294a90a6d40
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213603
Listing Expiration 2026-12-31
Marketing Start 2025-12-03

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69434043
Hyphenated Format 69434-043

Supplemental Identifiers

RxCUI
310430 310431 310432
UPC
0369434042049 0369434043046 0369434044043
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA213603 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 500 CAPSULE in 1 BOTTLE (69434-043-03)
  • 100 CAPSULE in 1 BOTTLE (69434-043-04)
source: ndc

Packages (2)

Ingredients (1)

gabapentin (300 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "457c0aa0-f1e5-d420-e063-6294a90a6d40", "openfda": {"nui": ["N0000008486"], "upc": ["0369434042049", "0369434043046", "0369434044043"], "unii": ["6CW7F3G59X"], "rxcui": ["310430", "310431", "310432"], "spl_set_id": ["f1eda6cc-d9b2-4df4-a09b-20eebded760f"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Zhejiang Yongtai Pharmaceutical Co., Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE (69434-043-03)", "package_ndc": "69434-043-03", "marketing_start_date": "20251203"}, {"sample": false, "description": "100 CAPSULE in 1 BOTTLE (69434-043-04)", "package_ndc": "69434-043-04", "marketing_start_date": "20251203"}], "brand_name": "Gabapentin", "product_id": "69434-043_457c0aa0-f1e5-d420-e063-6294a90a6d40", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "69434-043", "generic_name": "Gabapentin", "labeler_name": "Zhejiang Yongtai Pharmaceutical Co., Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA213603", "marketing_category": "ANDA", "marketing_start_date": "20251203", "listing_expiration_date": "20261231"}